Targeted therapy for head and neck cancer

New types of drugs known as targeted therapy are designed to attack specific changes within cancer cells. Targeted therapy for head and neck cancer works differently from chemotherapy drugs. While chemotherapy affects all rapidly dividing cells and kills cancerous cells (cytotoxic), targeted therapy drugs affect specific molecules within cells to block cell growth (cytostatic).

A number of targeted therapy drugs are being tested for head and neck cancer in clinical trials. One targeted therapy drug called cetuximab is available in Australia for head and neck cancers, when people cannot take the standard chemotherapy drug. Cetuximab is a monoclonal antibody that binds to the surface of cancer cells and stops them growing and dividing. When used to treat head and neck cancer, it is used with radiation therapy.

Listen to a podcast on New Cancer Treatments – Immunotherapy and Targeted Therapy

Video: What is targeted therapy?

Watch this short video to learn more about targeted and immunotherapy

This information was last reviewed in May 2017
View who reviewed this content
View our editorial policy

Support services

Coping with cancer?
Ask a health professional or someone who’s been there, or find a support group or forum

Need legal and financial assistance?
Pro bono legal and financial matters, no interest loans or help with small business

Looking for transport, accommodation or home help?
Practical advice and support during and after treatment

Work and cancer
Information for employees, employers and workplaces dealing with cancer

Cancer information

Making cancer treatment decisions
Decision-making steps, consent and second opinions

Chemotherapy common questions
Addresses chemotherapy concerns such as pain, time and pregnancy 

Cancer treatments: a video resource
A short video about surgery, chemotherapy and radiation therapy

View our publications
Guides and fact sheets for people with cancer, their families and friends